Trusted by 100,000+ International Patients
HIPEC: Turkey vs United Arab Emirates
Cost, Quality & Recovery Compared
$28500
Turkey Starting Cost
$45000
United Arab Emirates Starting Cost
See how these top medical tourism destinations compare for HIPEC.
| Comparison Factor | Turkey | United Arab Emirates | Winner |
|---|---|---|---|
| Average Cost (in USD) | 28500 - 40000 | 45000 - 75000 | Turkey |
| Success Rate (Min and Max) | 52% – 78% | 55% – 80% | United Arab Emirates |
| Advanced Technology | Tertiary surgical oncology hospitals with CRS+HIPEC capability and structured ICU pathways in major centres. | Advanced CRS + HIPEC programs in specialised oncology centres with modern perfusion systems, PET-CT imaging, and minimally invasive/robotic-assisted surgical support. | Both Equal |
| JCI Accredited Hospitals | 25+ | 15+ | Turkey |
| Visa Process | Medical Visa / e-Visa (5-10 days depending on nationality) | Medical Visa / Tourist Visa | Both Equal |
*Costs are estimates and may vary based on hospital, complexity, and package inclusions. See detailed cost breakdown below
Understand exactly where your money goes. Both countries offer all-inclusive packages, but here's how the costs typically break down.
Best for Budget-Conscious Patients
Offered Package Price (Additional Cost Excluded)
Top Hospitals: Liv Hospital Ulus , Medicana Camlica Hospital , Medicana Bahcelievler Hospital , Acibadem Hospital Taksim
Best for Flexible Donor Requirements
Offered Package Price (Additional Cost Excluded)
Want a personalized cost estimate based on your specific condition?
Get Your Free QuoteBoth Turkey and United Arab Emirates maintain world-class healthcare standards with internationally accredited hospitals and highly trained medical professionals.
25+ JCI-accredited hospitals and internationally recognised tertiary oncology centres.
Comparable tertiary centres follow European-aligned surgical oncology protocols for CRS+HIPEC.
Regulated under the Turkish Ministry of Health, oncology centres operate under national governance and drug safety standards.
Many hospitals in the UAE are accredited by the Joint Commission International (JCI) and regulated by the MOHAP, DHA, and DOH authorities.
HIPEC outcomes depend on cancer type, stage, and completeness of cytoreduction; UAE centres follow international oncology protocols and multidisciplinary tumour board approaches.
Healthcare is regulated by the Ministry of Health & Prevention (MOHAP), Dubai Health Authority (DHA), and Department of Health (DOH - Abu Dhabi), ensuring strict standards for oncology care and surgical safety.
| Quality Metric | Turkey | United Arab Emirates |
|---|---|---|
Accredited Hospitals | 25+ | 15+ |
CRS + HIPEC Availability | Yes | Yes |
ICU Support Level | Advanced (tertiary) | Advanced (tertiary & quaternary ICUs) |
Top Speciality Hospital Hubs | Istanbul, Ankara | Dubai, Abu Dhabi |
Both countries have highly qualified and experienced medical specialists trained at premier institutions worldwide. Here's what sets them apart.
Cancer Specialist
Concentrated in tertiary oncology hospitals; experience varies by centre.
Highly specialised surgical oncologists
Moderate to high procedural volume
Surgical Oncologist
Burjeel Hospital for Advanced Surgery Dubai Sharjah • 5 Years
All surgeons listed on Medigence are verified for their medical license, board certifications, hospital affiliations, and patient outcomes. We conduct background checks and regularly update our database to ensure you're connected with the best medical professionals.
Beyond medical excellence, your comfort during treatment matters. Compare the patient experience at top hospitals in both destinations.
World-class hospitals, exceptional value
Major oncology hospitals in Turkey are equipped with modern operating theatres, HIPEC perfusion technology for heated intraperitoneal chemotherapy, dedicated surgical oncology ICUs, advanced imaging (PET-CT, MRI), and integrated pathology and oncology pharmacy services. These facilities support comprehensive multidisciplinary cancer treatment.
Luxury healthcare experience
Top hospitals in the UAE feature advanced operating theatres, specialised HIPEC perfusion machines, surgical oncology ICUs, robotic surgery platforms, and comprehensive cancer care services, including pathology, molecular diagnostics, and advanced imaging systems.
Plan your medical journey with confidence. Here's everything you need to know about travel, visas, and accommodation in both countries.
We provide end-to-end travel assistance including visa facilitation, airport pickups, hotel bookings near your hospital, and local support throughout your stay. Our patient coordinators handle all logistics so you can focus on recovery.
Understanding the recovery process helps you plan better. Here's what to expect after HIPEC in both countries.
HIPEC is performed during cytoreductive surgery (CRS), where heated chemotherapy is circulated inside the abdominal cavity after tumour removal.
Patients usually require ICU monitoring immediately after surgery.
A short local stay after discharge is recommended for wound care, nutritional support, and recovery monitoring.
Recovery progresses gradually with dietary management, physiotherapy, and oncology follow-up visits.
In-person follow-ups recommended at 3, 6, 12 months. Telemedicine available.
HIPEC is performed alongside cytoreductive surgery to remove visible tumours and treat microscopic disease within the abdomen.
Patients require ICU monitoring immediately after surgery.
International patients are advised to stay locally for recovery and follow-up care.
Recovery improves gradually with nutrition, physiotherapy, and oncology follow-up.
Comprehensive telemedicine follow-up program. Return visits at 6, 12 months if possible.
HIPEC recipients require lifelong immunosuppressant medications. Ensure you have a plan for obtaining these medications and regular blood monitoring in your home country before traveling abroad for surgery.
Every medical procedure carries risks. We believe in complete transparency so you can make a fully informed decision about your HIPEC journey.
Higher-than-average surgical risk due to extensive cytoreduction; ICU and infection pathways are critical.
Expected due to major abdominal surgery; managed with protocols.
Possible due to nutritional depletion; requires nutrition optimisation.
Risk of bowel complications, anastomotic leak, and sepsis; it depends on the extent of surgery.
Chemo agent exposure can affect the kidneys and marrow; supportive monitoring is required.
The right choice depends on your specific situation. Here's a clear guide to help you decide which destination aligns with your needs.
Patients diagnosed with peritoneal surface malignancies, including colorectal cancer metastasis to the peritoneum, ovarian cancer, appendiceal cancer, or pseudomyxoma peritonei, who may benefit from cytoreductive surgery combined with heated intraperitoneal chemotherapy (HIPEC).
Patients with peritoneal malignancies such as colorectal cancer with peritoneal spread, ovarian cancer, appendix tumours, peritoneal mesothelioma, or pseudomyxoma peritonei who are suitable candidates for cytoreductive surgery with HIPEC.
Our medical tourism experts can analyze your case and recommend the best destination based on your medical history and budget.
Follow this step-by-step framework to make the right choice for your HIPEC journey.
Doctors confirm the diagnosis and assess the extent of peritoneal disease using the Peritoneal Cancer Index (PCI).
Surgeons evaluate whether complete cytoreduction (CC score) is achievable before recommending HIPEC.
Plan for ICU recovery, hospital stay, and post-operative monitoring.
The budget should include surgery, ICU stay, medications, and possible complications.
Follow-up imaging, blood tests, and additional therapies may be required after surgery.
Let our medical tourism experts guide you through the process. We'll help you:
No obligation • Free consultation • Response within 24 hours
Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More
